DUBAI, UAE. 25th September
2019: Ophthalmic Lasers Market size was
worth USD 1.0 billion in 2016, which is anticipated to grow at a CAGR of more
than 5.9% during the forecast period. Increase in incidence of chronic
ophthalmic disorders is the major driving factor contributing to the growth of
ophthalmic lasers market.
There is a rise in prevalence of ophthalmic disorders such
as glaucoma, cataract, refractive errors, Age Related Macular Degeneration
(AMD), retinal disorders and diabetic retinopathy. According to American
Academy of Ophthalmology in 2014, 60.5 million people were estimated to be
suffering from glaucoma globally. According to WHO, glaucoma is the second
major cause of blindness in the world.
Request Sample Copy @
https://www.millioninsights.com/industry-reports/ophthalmic-lasers-market/request-sample
Application Insights
On the basis of application, refractive error corrections
dominate the market in 2016. Rising incidence of refractive errors in children
and geriatric population has contributed towards the growth of this segment. In
addition, use of femtoseconds lasers in correcting eye disorders have also
contributed to the growth of this segment.
Cataract removal is expected to witness fastest growth over
the forecast period due to the increasing number of cataract removal surgeries
taking place across the globe. Cataract is a common problem in the geriatric
population which is the leading cause of blindness, if not given proper care at
the right time.
Glaucoma is the second leading cause of blindness, if not
given proper medical attention. This has eventually contributed to the
increased the demand for SLT and YAG lasers. Lumenis introduced a product,
Smart Select Duet, which uses the combination of SLT and YAG lasers for
treating glaucoma.
Retinal disease such as AMD and diabetic retinopathy are the
common problem of geriatric population. According to the American Academy of
Ophthalmology, 60% of people with diabetes develop diabetic retinopathy. The
major players are focussing on production of products which are helpful in
correcting such eye disorders. For instance, Topcon Corporation manufactured
PASCAL Synthesis System for the treatment diabetic retinopathy and AMD.
End use Insights
On the basis of the end-use, hospital held the largest
market share in 2016 due to the large number of ophthalmic lasers being
performed in hospitals. The rising number of hospitals in the developing
countries with the support of the government also contributes to the growth of
this segment.
Browse Complete
Report with TOC @ https://www.millioninsights.com/industry-reports/ophthalmic-lasers-market
Ophthalmic Lasers
Application Outlook (Revenue, USD Million, 2014 - 2025)
• Glaucoma
• Cataract
Removal
• Refractive
Error Corrections
• Diabetic
Retinopathy
• AMD
• Others
Ophthalmic Lasers
End-use Outlook (Revenue, USD Million, 2014 - 2025)
• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic
Clinics
For More Information,
Visit Our Blog @ www.digitalmarket360.wordpress.com
No comments:
Post a Comment